Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Industry: Biotechnology

Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Biotech is Zen Rated F and is the 141st ranked industry out of 145 stock market industries

Ticker	Company	Price	1d %	1w %	1m %	3m %	6m %	1y %	3y %	5y %	10y %	52-week High	52-week Low	% off 52-week High	% off 52-week Low	Beta	Volume	Vol 1d %
PBYI	PUMA BIOTECHNOLOGY INC	$3.18	-4.79%	-8.36%	-7.29%	4.61%	3.58%	-11.91%	8.53%	-67.75%	-96.21%	$4.13	$2.23	23.00%	42.92%	0.99	324,000	-6.90%
RIGL	RIGEL PHARMACEUTICALS INC	$19.90	-0.45%	-0.80%	6.25%	1.69%	-11.52%	87.56%	67.23%	-14.96%	-30.18%	$29.82	$8.61	33.27%	131.13%	1.30	251,000	105.74%
PTCT	PTC THERAPEUTICS INC	$49.29	11.16%	6.25%	0.92%	-0.46%	9.00%	51.57%	13.18%	4.81%	-3.39%	$58.38	$29.02	15.57%	69.88%	0.99	2,980,000	202.23%
AUPH	AURINIA PHARMACEUTICALS INC	$8.95	0.62%	0.73%	5.61%	10.16%	9.89%	57.48%	9.35%	-32.18%	142.41%	$10.67	$5.20	16.17%	72.18%	1.08	974,000	25.03%
INCY	INCYTE CORP	$77.38	10.28%	12.30%	13.62%	28.04%	4.96%	12.81%	-0.39%	-21.08%	-25.41%	$83.95	$53.56	7.83%	44.46%	0.59	3,976,000	106.33%
CRMD	CORMEDIX INC	$11.64	-2.84%	5.24%	-5.52%	27.63%	3.10%	148.72%	117.57%	148.19%	-27.93%	$17.43	$3.61	33.22%	222.44%	0.98	1,505,000	-31.56%
BCRX	BIOCRYST PHARMACEUTICALS INC	$8.09	-2.06%	-6.47%	-9.71%	-4.15%	0.87%	7.58%	-26.59%	91.71%	-46.99%	$11.31	$6.02	28.47%	34.50%	1.20	3,502,000	7.95%
HALO	HALOZYME THERAPEUTICS INC	$59.05	2.29%	2.62%	13.51%	-2.91%	5.77%	6.45%	20.76%	121.49%	152.03%	$70.51	$42.01	16.25%	40.56%	0.86	1,446,000	35.01%
NAGE	NIAGEN BIOSCIENCE INC	$9.66	-0.31%	2.22%	-32.96%	24.16%	63.73%	231.96%	461.63%	91.67%	187.50%	$14.69	$2.53	34.24%	281.82%	1.28	966,000	-44.61%
KNSA	KINIKSA PHARMACEUTICALS INTERNATIONAL PLC	$30.37	12.32%	9.88%	9.76%	17.35%	47.00%	16.18%	206.46%	56.87%	N/A	$31.92	$17.82	4.86%	70.43%	0.87	1,679,000	150.60%
CPRX	CATALYST PHARMACEUTICALS INC	$21.02	1.03%	0.55%	-3.16%	-13.45%	-12.29%	20.22%	105.22%	362.89%	327.13%	$26.58	$15.34	20.94%	36.99%	1.06	1,260,000	-3.45%
ZVRA	ZEVRA THERAPEUTICS INC	$10.81	0.00%	-6.65%	22.70%	49.52%	37.53%	85.10%	93.04%	95.83%	-95.90%	$13.16	$5.95	17.86%	81.68%	0.81	778,000	-28.75%
BMRN	BIOMARIN PHARMACEUTICAL INC	$58.23	0.15%	-1.64%	5.93%	-7.98%	-8.24%	-30.74%	-32.33%	-51.69%	-59.65%	$94.85	$52.93	38.61%	10.01%	0.76	1,423,000	23.20%
ALNY	ALNYLAM PHARMACEUTICALS INC	$330.55	1.77%	1.62%	1.37%	28.52%	20.64%	39.90%	132.72%	119.55%	154.09%	$333.70	$205.87	0.94%	60.56%	0.93	862,000	-15.07%
AKBA	AKEBIA THERAPEUTICS INC	$3.51	-2.23%	-8.83%	-3.57%	44.44%	52.61%	150.71%	797.70%	-70.15%	-62.50%	$4.08	$1.07	13.95%	228.04%	1.66	2,672,000	-4.16%
ONC	BEONE MEDICINES LTD	$305.74	3.81%	3.43%	26.30%	22.41%	34.86%	89.97%	81.90%	46.64%	N/A	$308.87	$155.75	1.01%	96.30%	0.96	789,000	96.76%
BDTX	BLACK DIAMOND THERAPEUTICS INC	$2.78	-5.12%	-12.85%	12.10%	73.75%	13.93%	-53.82%	-20.57%	-90.23%	N/A	$6.75	$1.20	58.81%	132.64%	1.48	1,298,000	142.16%
VCYT	VERACYTE INC	$24.47	-2.20%	4.08%	-9.47%	-22.02%	-44.94%	6.25%	-7.10%	-18.92%	116.74%	$47.32	$19.73	48.28%	24.02%	1.93	2,302,000	-85.21%
PLX	PROTALIX BIOTHERAPEUTICS INC	$1.46	-2.67%	-7.59%	-1.35%	-50.68%	-38.40%	31.53%	37.74%	-59.44%	-91.15%	$3.10	$0.82	52.90%	77.83%	0.64	456,000	0.44%
IMCR	IMMUNOCORE HOLDINGS PLC	$33.91	-0.09%	-8.72%	8.06%	11.29%	7.17%	-14.67%	-26.51%	N/A	N/A	$40.52	$23.15	16.31%	46.48%	0.75	441,000	118.32%
IPA	IMMUNOPRECISE ANTIBODIES LTD	$1.73	-14.60%	1.47%	62.74%	289.39%	275.00%	107.83%	-59.22%	N/A	N/A	$2.41	$0.27	28.42%	538.89%	0.79	2,837,000	103.52%
INVA	INNOVIVA INC	$18.46	-0.43%	-4.25%	-8.11%	-0.32%	-2.28%	-2.17%	28.73%	38.90%	18.18%	$22.00	$16.67	16.09%	10.74%	0.47	475,000	-39.95%
NVO	NOVO NORDISK A S	$53.94	-21.83%	-19.23%	-21.85%	-17.22%	-35.81%	-57.88%	-7.05%	61.21%	81.77%	$139.74	$53.51	61.40%	0.80%	0.61	110,210,000	1,511.26%
HRMY	HARMONY BIOSCIENCES HOLDINGS INC	$35.45	-0.87%	-3.38%	12.18%	20.41%	-8.68%	4.82%	-30.12%	N/A	N/A	$41.61	$26.47	14.80%	33.93%	0.85	491,000	-27.58%
EXEL	EXELIXIS INC	$36.94	-16.78%	-16.93%	-16.19%	-4.18%	12.08%	59.84%	76.58%	54.82%	559.64%	$49.62	$23.13	25.55%	59.71%	0.64	15,741,000	140.47%
XLO	XILIO THERAPEUTICS INC	$0.70	2.64%	0.00%	2.94%	-7.41%	-2.23%	-28.57%	-75.86%	N/A	N/A	$1.70	$0.62	58.82%	12.90%	0.92	310,000	179.28%
GMAB	GENMAB A	$22.60	-2.12%	3.67%	9.39%	8.71%	13.85%	-20.65%	-36.55%	-35.76%	132.22%	$28.56	$17.24	20.87%	31.13%	0.74	827,000	26.84%
FENC	FENNEC PHARMACEUTICALS INC	$8.54	-1.39%	-0.35%	2.89%	37.96%	31.99%	36.20%	27.84%	4.53%	281.25%	$9.30	$3.96	8.17%	115.66%	0.69	27,200	-47.69%
MNKD	MANNKIND CORP	$3.82	-3.54%	-2.80%	2.14%	-22.20%	-37.48%	-34.36%	10.72%	138.75%	-82.79%	$7.63	$3.51	49.93%	8.83%	1.11	4,339,000	92.16%
ZYME	ZYMEWORKS INC	$13.51	0.37%	-5.66%	7.65%	6.46%	-7.53%	27.45%	131.34%	-53.75%	N/A	$17.70	$9.03	23.67%	49.61%	0.94	354,000	27.80%
HRTX	HERON THERAPEUTICS INC	$1.85	-0.54%	-2.63%	-10.63%	-20.94%	10.78%	-36.86%	-33.45%	-89.03%	-94.34%	$3.01	$1.04	38.54%	77.88%	1.49	864,000	1.77%
XOMA	XOMA ROYALTY CORP	$26.47	0.91%	4.01%	5.04%	8.57%	-0.11%	-2.90%	12.64%	56.53%	59.46%	$35.00	$18.35	24.37%	44.23%	0.86	21,400	7.00%
KROS	KEROS THERAPEUTICS INC	$14.48	-0.21%	5.46%	8.46%	0.21%	27.35%	-72.17%	-54.86%	-52.43%	N/A	$72.37	$9.12	79.99%	58.77%	1.14	267,000	-14.70%
WHWK	WHITEHAWK THERAPEUTICS INC	$1.77	-2.21%	-5.35%	-5.35%	20.41%	-38.75%	11.32%	-85.69%	-91.06%	N/A	$3.81	$1.21	53.57%	46.28%	0.81	99,500	13.07%
TBPH	THERAVANCE BIOPHARMA INC	$11.03	-0.27%	-1.78%	0.00%	16.11%	14.54%	9.10%	25.48%	-45.45%	-7.70%	$11.88	$7.44	7.15%	48.25%	0.63	133,000	-11.92%
IMAB	I-MAB	$1.70	-9.09%	-18.27%	-29.75%	109.36%	61.90%	25.00%	-83.78%	-94.37%	N/A	$3.08	$0.60	44.72%	185.71%	1.20	582,000	3.37%
MDXG	MIMEDX GROUP INC	$6.67	-1.77%	-1.33%	9.17%	-3.61%	-26.30%	-12.47%	95.03%	N/A	-46.25%	$10.14	$5.47	34.22%	21.94%	1.22	567,000	-26.36%
MIRM	MIRUM PHARMACEUTICALS INC	$51.17	-0.62%	-1.95%	0.55%	20.29%	5.29%	21.69%	103.86%	152.57%	N/A	$54.73	$36.20	6.50%	41.35%	0.76	297,000	20.73%
ZLAB	ZAI LAB LTD	$40.51	4.70%	9.49%	15.84%	27.23%	48.72%	115.59%	-0.05%	-45.90%	N/A	$44.34	$16.01	8.64%	153.03%	1.28	1,428,000	31.01%
RPRX	ROYALTY PHARMA PLC	$37.27	0.57%	3.24%	3.44%	13.94%	16.65%	29.86%	-14.30%	-13.43%	N/A	$37.57	$24.05	0.79%	54.97%	0.52	1,982,000	-25.09%
ATRA	ATARA BIOTHERAPEUTICS INC	$11.73	-0.68%	-9.91%	51.94%	56.19%	44.99%	12.79%	-84.51%	-96.32%	-99.20%	$18.71	$5.01	37.29%	134.37%	1.85	47,600	12.53%
TECH	BIO-TECHNE CORP	$57.87	-1.16%	8.94%	12.48%	14.59%	-19.43%	-27.41%	-39.92%	-15.63%	111.05%	$83.62	$46.01	30.79%	25.78%	1.17	2,056,000	-29.01%
XERS	XERIS BIOPHARMA HOLDINGS INC	$5.00	-1.38%	-2.34%	7.07%	13.38%	36.99%	98.41%	252.11%	85.19%	N/A	$6.07	$2.10	17.63%	138.66%	1.19	1,138,000	0.26%
ACAD	ACADIA PHARMACEUTICALS INC	$22.63	0.04%	0.27%	4.91%	56.83%	23.19%	20.69%	54.05%	-46.79%	-53.44%	$25.23	$13.40	10.31%	68.88%	0.89	1,932,000	-0.97%
AGEN	AGENUS INC	$5.88	-7.40%	-3.92%	28.67%	92.79%	62.88%	-9.40%	-88.60%	-90.13%	-96.43%	$7.34	$1.38	19.89%	326.09%	1.66	873,000	-28.85%
VRTX	VERTEX PHARMACEUTICALS INC	$468.41	1.64%	-0.37%	5.21%	-6.97%	6.09%	-5.97%	67.04%	68.06%	272.88%	$519.88	$377.85	9.90%	23.97%	0.59	1,147,000	-45.48%
ARGX	ARGENX SE	$598.79	0.60%	4.82%	8.63%	-4.88%	-8.55%	19.99%	64.41%	140.02%	N/A	$678.21	$475.65	11.71%	25.89%	0.67	247,000	-33.24%
ARWR	ARROWHEAD PHARMACEUTICALS INC	$15.92	-1.73%	6.42%	0.76%	18.19%	-20.20%	-44.45%	-62.57%	-64.06%	157.40%	$29.47	$9.57	45.98%	66.35%	1.59	1,598,000	-11.12%
FHTX	FOGHORN THERAPEUTICS INC	$5.91	-9.15%	-6.86%	25.64%	38.94%	48.37%	-13.67%	-59.64%	N/A	N/A	$10.25	$2.95	42.39%	100.51%	1.48	150,000	32.74%
CSBR	CHAMPIONS ONCOLOGY INC	$6.42	1.90%	-18.16%	-12.89%	-14.63%	-42.11%	28.92%	-25.87%	-29.06%	21.59%	$11.99	$3.60	46.46%	78.33%	0.46	20,400	-61.94%
TGTX	TG THERAPEUTICS INC	$35.33	-1.83%	-5.46%	-1.83%	-19.45%	5.87%	78.34%	489.82%	83.15%	106.49%	$46.48	$16.65	23.99%	112.19%	1.93	1,389,000	-20.67%
STOK	STOKE THERAPEUTICS INC	$12.50	-2.42%	-7.89%	10.13%	31.44%	18.93%	-15.54%	-15.48%	-52.56%	N/A	$16.15	$5.35	22.60%	133.64%	1.38	823,000	32.10%
LGND	LIGAND PHARMACEUTICALS INC	$131.58	-2.48%	-0.66%	15.75%	18.14%	10.65%	20.99%	42.98%	5.60%	23.13%	$143.05	$90.29	8.02%	45.73%	1.10	99,000	-15.38%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$14.99	0.20%	3.02%	6.92%	1.63%	9.26%	56.64%	-38.21%	-45.61%	N/A	$17.75	$7.86	15.55%	90.71%	1.19	1,255,000	-10.93%
ADPT	ADAPTIVE BIOTECHNOLOGIES CORP	$10.39	-2.07%	-1.33%	-10.82%	36.53%	34.76%	134.01%	13.43%	-72.94%	N/A	$12.43	$3.85	16.41%	170.22%	1.99	1,011,000	-14.25%
CTMX	CYTOMX THERAPEUTICS INC	$2.25	-5.86%	-5.86%	-0.88%	245.09%	174.39%	58.45%	57.34%	-69.05%	N/A	$3.10	$0.40	27.30%	462.50%	1.31	2,734,000	105.10%
AAPG	ASCENTAGE PHARMA GROUP INTERNATIONAL	$40.08	2.06%	1.75%	1.79%	65.62%	131.28%	N/A	N/A	N/A	N/A	$43.58	$17.00	8.03%	135.76%	0.55	4,800	-50.52%
NEUP	NEUPHORIA THERAPEUTICS INC	$8.56	-1.50%	11.17%	20.56%	65.41%	64.30%	6.06%	-89.11%	N/A	N/A	$12.55	$2.12	31.79%	303.01%	0.72	42,000	-28.33%
UTHR	UNITED THERAPEUTICS CORP	$297.56	-0.19%	-0.11%	3.55%	-1.06%	-20.17%	-11.25%	28.77%	163.96%	77.99%	$417.82	$266.98	28.78%	11.45%	0.48	527,000	6.04%
CORT	CORCEPT THERAPEUTICS INC	$68.20	-1.37%	-1.27%	-7.08%	-6.87%	10.84%	86.70%	137.96%	322.55%	1,258.57%	$117.33	$32.33	41.87%	110.95%	0.95	853,000	2.77%
NVAX	NOVAVAX INC	$7.01	-3.71%	-2.91%	11.27%	9.19%	-20.43%	-57.31%	-87.14%	-95.18%	-97.06%	$15.22	$5.01	53.94%	39.92%	1.70	4,898,000	11.17%
LYEL	LYELL IMMUNOPHARMA INC	$12.87	-6.26%	25.19%	45.59%	48.92%	10.99%	-58.75%	-88.45%	N/A	N/A	$33.90	$7.65	62.04%	68.24%	1.55	111,000	-56.47%
IPSC	CENTURY THERAPEUTICS INC	$0.58	-8.75%	1.57%	4.47%	15.87%	-29.13%	-74.27%	-94.47%	N/A	N/A	$2.29	$0.34	74.50%	70.76%	1.26	2,008,000	-14.52%
RGNX	REGENXBIO INC	$8.41	-4.32%	-1.87%	2.44%	-10.63%	11.84%	-41.39%	-73.19%	-75.60%	N/A	$15.02	$5.04	44.01%	67.03%	1.39	936,000	63.92%
GLUE	MONTE ROSA THERAPEUTICS INC	$5.26	-5.23%	-7.07%	16.63%	9.81%	-12.19%	15.10%	-42.01%	N/A	N/A	$12.40	$3.50	57.58%	50.29%	1.69	372,000	-18.24%
SEER	SEER INC	$2.18	-0.91%	1.40%	1.87%	12.95%	-6.44%	10.10%	-75.78%	N/A	N/A	$2.63	$1.59	16.95%	37.54%	1.81	82,000	20.59%
SEPN	SEPTERNA INC	$12.75	-7.81%	2.25%	20.62%	83.98%	-18.01%	N/A	N/A	N/A	N/A	$28.99	$4.17	56.02%	205.76%	1.44	330,000	132.39%
ACIU	AC IMMUNE SA	$2.35	-0.84%	1.73%	15.76%	38.24%	-10.98%	-41.98%	-33.24%	-64.53%	N/A	$4.26	$1.43	44.84%	64.34%	1.13	263,000	67.52%
ACOG	ALPHA COGNITION INC	$9.25	-4.93%	-5.61%	-0.86%	75.52%	46.36%	N/A	N/A	N/A	N/A	$11.54	$3.75	19.84%	146.67%	0.87	98,000	133.33%
SPRO	SPERO THERAPEUTICS INC	$2.20	-4.35%	-8.71%	-24.14%	227.87%	155.81%	52.78%	200.55%	-81.70%	N/A	$3.22	$0.51	31.68%	335.64%	0.67	879,000	197.97%
MCRB	SERES THERAPEUTICS INC	$12.15	-8.23%	-1.94%	9.36%	29.26%	-24.54%	-57.52%	-85.22%	-85.07%	-98.39%	$28.20	$6.53	56.91%	86.06%	1.37	72,000	-49.65%
MDGL	MADRIGAL PHARMACEUTICALS INC	$294.40	0.08%	-6.06%	-2.72%	-13.62%	-9.78%	7.18%	368.64%	185.00%	298.65%	$377.46	$200.63	22.00%	46.74%	0.79	260,000	-10.96%
TVTX	TRAVERE THERAPEUTICS INC	$15.53	0.84%	-0.83%	4.93%	-22.66%	-24.06%	52.40%	-34.03%	-23.12%	-51.48%	$25.29	$7.93	38.59%	95.81%	1.07	1,026,000	16.33%
ZYBT	ZHENGYE BIOTECHNOLOGY HOLDING LTD	$5.50	-4.35%	0.36%	-7.87%	-41.11%	21.41%	N/A	N/A	N/A	N/A	$14.30	$3.50	61.54%	57.14%	1.46	17,000	-15.00%
ASND	ASCENDIS PHARMA A	$163.32	-0.51%	-1.34%	-5.38%	-1.96%	28.04%	21.65%	90.95%	18.96%	719.47%	$183.00	$111.09	10.75%	47.02%	0.72	337,000	-22.53%
TSHA	TAYSHA GENE THERAPIES INC	$2.62	-1.87%	-0.38%	13.42%	43.96%	74.67%	14.41%	-35.63%	N/A	N/A	$3.31	$1.05	20.85%	149.52%	1.81	1,518,000	13.28%
IONS	IONIS PHARMACEUTICALS INC	$41.48	0.75%	-1.12%	4.99%	39.15%	26.16%	-17.44%	10.44%	-29.43%	-21.81%	$51.62	$23.95	19.64%	73.19%	0.86	1,467,000	-8.31%
NTRB	NUTRIBAND INC	$7.54	-6.57%	-13.03%	-4.19%	32.75%	3.15%	3.01%	71.79%	-2.26%	N/A	$11.78	$3.72	35.99%	102.58%	0.59	24,300	-29.15%
HLVX	HILLEVAX INC	$2.11	-0.94%	0.00%	6.03%	9.33%	8.21%	12.23%	-84.39%	N/A	N/A	$2.17	$1.34	2.76%	57.46%	1.09	56,400	-32.86%
FTRE	FORTREA HOLDINGS INC	$6.36	-7.42%	9.66%	28.74%	0.47%	-61.45%	-76.69%	N/A	N/A	N/A	$27.99	$3.97	77.28%	60.20%	1.52	1,578,000	-20.58%
FOLD	AMICUS THERAPEUTICS INC	$6.13	0.16%	-1.45%	6.98%	-18.48%	-36.08%	-39.37%	-38.45%	-57.78%	-63.01%	$12.65	$5.51	51.54%	11.25%	1.03	3,571,000	-19.57%
ATAI	ATAI LIFE SCIENCES NV	$3.31	-0.60%	-6.23%	51.14%	134.75%	120.67%	109.49%	-14.25%	N/A	N/A	$4.00	$1.03	17.25%	221.36%	1.41	6,433,000	-35.13%
KRYS	KRYSTAL BIOTECH INC	$152.08	-0.54%	0.12%	10.64%	-10.84%	-2.70%	-25.88%	109.53%	267.52%	N/A	$212.06	$122.80	28.28%	23.84%	1.37	195,000	-56.76%
TARS	TARSUS PHARMACEUTICALS INC	$40.14	-3.86%	-5.20%	-0.91%	-21.14%	-24.36%	64.98%	167.24%	N/A	N/A	$57.28	$20.08	29.92%	99.88%	0.90	660,000	20.22%
CADL	CANDEL THERAPEUTICS INC	$6.57	-4.23%	-1.50%	29.84%	35.74%	-1.05%	6.48%	111.94%	N/A	N/A	$14.60	$3.79	55.00%	73.58%	1.08	840,000	25.75%
GYRE	GYRE THERAPEUTICS INC	$7.30	-6.53%	0.97%	-0.68%	-23.72%	-36.41%	-51.01%	-72.19%	-90.50%	-99.82%	$19.00	$6.11	61.58%	19.48%	1.23	62,400	-25.71%
ERAS	ERASCA INC	$1.55	-8.82%	-7.74%	22.05%	8.39%	-15.76%	-52.31%	-79.44%	N/A	N/A	$3.31	$1.01	53.10%	53.47%	1.44	1,010,000	11.73%
LEGN	LEGEND BIOTECH CORP	$40.77	-1.78%	-7.38%	14.88%	18.41%	12.94%	-27.69%	-13.70%	13.41%	N/A	$59.62	$27.34	31.62%	49.12%	0.77	1,201,000	-1.15%
ARVN	ARVINAS INC	$7.48	-1.71%	-1.32%	1.63%	-20.17%	-57.38%	-73.07%	-85.92%	-77.32%	N/A	$29.61	$5.90	74.74%	26.78%	1.35	1,932,000	8.78%
TLX	TELIX PHARMACEUTICALS LTD	$13.49	-3.37%	-17.14%	-16.05%	-22.29%	-27.43%	N/A	N/A	N/A	N/A	$30.36	$13.35	55.57%	1.05%	0.85	52,000	-38.82%
TAOX	TAO SYNERGIES INC	$6.86	5.21%	-23.01%	-12.61%	188.84%	92.05%	67.32%	-95.77%	N/A	N/A	$11.98	$1.84	42.74%	272.83%	1.06	206,000	-50.12%
IMNM	IMMUNOME INC	$10.60	-2.21%	-4.25%	13.98%	24.12%	13.37%	-32.74%	172.84%	N/A	N/A	$16.73	$5.15	36.64%	105.83%	1.44	693,000	22.87%
TNXP	TONIX PHARMACEUTICALS HOLDING CORP	$42.63	-9.87%	-4.74%	18.48%	145.00%	-0.86%	-24.68%	-99.87%	-99.99%	-100.00%	$130.00	$6.76	67.21%	530.62%	1.16	2,085,000	6.32%
CDTX	CIDARA THERAPEUTICS INC	$61.93	-1.20%	0.65%	27.14%	193.23%	246.95%	374.56%	294.46%	-19.99%	-77.63%	$66.95	$10.14	7.49%	510.75%	0.76	205,000	-28.32%
YMAB	Y-MABS THERAPEUTICS INC	$4.97	1.84%	12.70%	10.20%	18.33%	-19.19%	-59.09%	-68.12%	-86.25%	N/A	$16.11	$3.55	69.15%	40.00%	1.53	230,000	48.39%
REGN	REGENERON PHARMACEUTICALS INC	$558.15	-0.09%	-0.50%	6.31%	-1.89%	-18.79%	-48.19%	-4.05%	-11.71%	2.17%	$1.21k	$476.49	53.92%	17.14%	0.64	815,000	38.61%
PHIO	PHIO PHARMACEUTICALS CORP	$2.54	0.40%	0.79%	8.09%	28.28%	11.40%	-27.22%	-96.71%	-99.02%	-100.00%	$9.79	$0.97	74.06%	162.94%	1.05	554,000	-45.79%
PVLA	PALVELLA THERAPEUTICS INC	$38.88	-2.48%	8.00%	72.49%	65.87%	192.11%	137.80%	-72.39%	-81.87%	-84.17%	$40.50	$11.17	4.00%	248.08%	0.78	332,000	32.27%
AVXL	ANAVEX LIFE SCIENCES CORP	$11.36	-1.82%	1.70%	23.21%	17.96%	17.11%	61.36%	10.72%	153.57%	259.49%	$14.44	$4.93	21.34%	130.43%	1.73	717,000	-70.01%
LCTX	LINEAGE CELL THERAPEUTICS INC	$1.07	-8.55%	12.63%	17.58%	127.18%	77.45%	4.90%	-34.76%	27.84%	-66.03%	$1.21	$0.37	11.57%	193.15%	1.07	1,852,000	1.81%

Biotech Stocks FAQ

What are the best biotech stocks to buy right now in Jul 2025?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best biotechnology stocks to buy right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the #1 top biotech stock out of 642 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Puma Biotechnology (NASDAQ:PBYI) is: Value: A, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Puma Biotechnology (NASDAQ:PBYI) has a Due Diligence Score of 49, which is 26 points higher than the biotech industry average of 23.

PBYI passed 16 out of 33 due diligence checks and has strong fundamentals. Puma Biotechnology has seen its stock lose -11.91% over the past year, overperforming other biotech stocks by 58 percentage points.

Puma Biotechnology has an average 1 year price target of $7.00, an upside of 120.13% from Puma Biotechnology's current stock price of $3.18.

Puma Biotechnology stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Puma Biotechnology, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

Rigel Pharmaceuticals (NASDAQ:RIGL) is the #2 top biotech stock out of 642 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Rigel Pharmaceuticals (NASDAQ:RIGL) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: C, Financials: B, and AI: C.

Rigel Pharmaceuticals (NASDAQ:RIGL) has a Due Diligence Score of 35, which is 12 points higher than the biotech industry average of 23.

RIGL passed 11 out of 33 due diligence checks and has average fundamentals. Rigel Pharmaceuticals has seen its stock return 87.56% over the past year, overperforming other biotech stocks by 157 percentage points.

Rigel Pharmaceuticals has an average 1 year price target of $39.75, an upside of 99.75% from Rigel Pharmaceuticals's current stock price of $19.90.

Rigel Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Rigel Pharmaceuticals, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Ptc Therapeutics (NASDAQ:PTCT)

Ptc Therapeutics (NASDAQ:PTCT) is the #3 top biotech stock out of 642 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Ptc Therapeutics (NASDAQ:PTCT) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: C, Financials: A, and AI: C.

Ptc Therapeutics (NASDAQ:PTCT) has a Due Diligence Score of 35, which is 12 points higher than the biotech industry average of 23.

PTCT passed 11 out of 33 due diligence checks and has average fundamentals. Ptc Therapeutics has seen its stock return 51.57% over the past year, overperforming other biotech stocks by 121 percentage points.

Ptc Therapeutics has an average 1 year price target of $69.62, an upside of 41.24% from Ptc Therapeutics's current stock price of $49.29.

Ptc Therapeutics stock has a consensus Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Ptc Therapeutics, 53.85% have issued a Strong Buy rating, 15.38% have issued a Buy, 23.08% have issued a hold, while 0% have issued a Sell rating, and 7.69% have issued a Strong Sell.

What are the biotech stocks with highest dividends?

Out of 5 biotech stocks that have issued dividends in the past year, the 3 biotech stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 6.6%, which is 5 percentage points higher than the biotech industry average of 1.74%.

Dominari Holdings's dividend payout ratio of -7.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Novo Nordisk (Ozempic) (NYSE:NVO)

Novo Nordisk (Ozempic) (NYSE:NVO) has an annual dividend yield of 2.99%, which is 1 percentage points higher than the biotech industry average of 1.74%. Novo Nordisk (Ozempic)'s dividend payout is not stable, having dropped more than 10% ten times in the last 10 years. Novo Nordisk (Ozempic)'s dividend has shown consistent growth over the last 10 years.

Novo Nordisk (Ozempic)'s dividend payout ratio of 45.2% indicates that its dividend yield is sustainable for the long-term.

3. Royalty Pharma (NASDAQ:RPRX)

Royalty Pharma (NASDAQ:RPRX) has an annual dividend yield of 1.74%, which is the same as the biotech industry average of 1.74%. Royalty Pharma's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Royalty Pharma's dividend has shown consistent growth over the last 10 years.

Royalty Pharma's dividend payout ratio of 34.4% indicates that its dividend yield is sustainable for the long-term.

Why are biotech stocks down?

Biotech stocks were down -1.1% in the last day, and up 0.42% over the last week. Aim Immunotech was the among the top losers in the biotechnology industry, dropping -56.25% yesterday.

AIM ImmunoTech shares are trading lower after the company announced a $8 million public offering consisting of shares as well as class E and F warrants.

What are the most undervalued biotech stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued biotech stocks right now are:

1. Puma Biotechnology (NASDAQ:PBYI)

Puma Biotechnology (NASDAQ:PBYI) is the most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Puma Biotechnology has a valuation score of 43, which is 29 points higher than the biotech industry average of 14. It passed 3 out of 7 valuation due diligence checks.

Puma Biotechnology's stock has dropped -11.91% in the past year. It has overperformed other stocks in the biotech industry by 58 percentage points.

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

Harmony Biosciences Holdings (NASDAQ:HRMY) is the second most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Harmony Biosciences Holdings has a valuation score of 71, which is 57 points higher than the biotech industry average of 14. It passed 5 out of 7 valuation due diligence checks.

Harmony Biosciences Holdings's stock has gained 4.82% in the past year. It has overperformed other stocks in the biotech industry by 75 percentage points.

3. Rigel Pharmaceuticals (NASDAQ:RIGL)

Rigel Pharmaceuticals (NASDAQ:RIGL) is the third most undervalued biotech stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Rigel Pharmaceuticals has a valuation score of 29, which is 15 points higher than the biotech industry average of 14. It passed 2 out of 7 valuation due diligence checks.

Rigel Pharmaceuticals's stock has gained 87.56% in the past year. It has overperformed other stocks in the biotech industry by 157 percentage points.

Are biotech stocks a good buy now?

53.72% of biotech stocks rated by analysts are a strong buy right now. On average, analysts expect biotech stocks to rise by 100.87% over the next year.

2.1% of biotech stocks have a Zen Rating of A (Strong Buy), 4.61% of biotech stocks are rated B (Buy), 37.11% are rated C (Hold), 36.06% are rated D (Sell), and 20.13% are rated F (Strong Sell).

What is the average p/e ratio of the biotechnology industry?

The average P/E ratio of the biotechnology industry is -195.28x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

3. Ptc Therapeutics (NASDAQ:PTCT)

1. Dominari Holdings (NASDAQ:DOMH)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Puma Biotechnology (NASDAQ:PBYI)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Rigel Pharmaceuticals (NASDAQ:RIGL)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBiotechnologyBest Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.

Biotech Stocks FAQ

1. Puma Biotechnology (NASDAQ:PBYI)

2. Rigel Pharmaceuticals (NASDAQ:RIGL)

3. Ptc Therapeutics (NASDAQ:PTCT)

1. Dominari Holdings (NASDAQ:DOMH)

2. Novo Nordisk (Ozempic) (NYSE:NVO)

3. Royalty Pharma (NASDAQ:RPRX)

1. Puma Biotechnology (NASDAQ:PBYI)

2. Harmony Biosciences Holdings (NASDAQ:HRMY)

3. Rigel Pharmaceuticals (NASDAQ:RIGL)

Company

Stock Tools

Stock Ideas

Sectors & Industries HealthcareBiotechnology
Best Biotech Stocks to Buy Now (2025)
Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.